Ben-Gurion University of the Negev has developed an engineered, ordered cellulosome-based immobilization system to improve cell-free biochemical manufacturing. By organizing enzymes on a scaffoldin-mediated platform, this approach facilitates substrate channeling and overcomes diffusion-limited mass transfer, significantly enhancing enzymatic productivity. The system has been validated as a proof-of-concept for isobutanol production, offering a versatile platform for future sustainable biofuel and biochemical synthesis.
This research introduces an engineered, ordered cellulosome-based immobilization system designed to enhance enzymatic productivity in cell-free biochemical manufacturing. By moving beyond traditional enzyme engineering, this approach addresses the diffusion-limited mass transfer constraints that often hinder in vitro production systems. The platform utilizes targeted, scaffoldin-mediated immobilization to organize enzymes, facilitating substrate channeling and improving overall reaction efficiency. This technology serves as a versatile, proof-of-concept platform for the future production of biofuels and biochemicals.
The technology is at a TRL of 3. It is currently a proof-of-concept research approach demonstrated in a laboratory setting, as evidenced by the successful application of the model pathway to achieve specific titer and yield metrics in a controlled study.
Ben-Gurion University of the Negev is a comprehensive public research university with roughly 20,000 students across campuses in Be’er Sheva, Sde Boker, and Eilat. Industry engages through the Advanced Technologies Park next to the main campus and a dedicated tech transfer company that streamlines IP, sponsored research, and co-development. Integration with Soroka University Medical Center supports clinical translation, and Cyber@BGU within Israel’s national cyber hub links faculty to startups, multinationals, and public-sector partners. Research is funded by the Israel Science Foundation, European Research Council programs (Horizon Europe/H2020), the Israel Innovation Authority, and US–Israel binational funds. Commercialization is led by BGN Technologies, with venture-building through the Yazamut 360 entrepreneurship center.